Why the study?
Does transapical implantation of artificial chordae using the NeoChord system safely and effectively reduce mitral regurgitation in patients with severe MR?
Does transapical implantation of artificial chordae using the NeoChord system safely and effectively reduce mitral regurgitation in patients with severe MR?
Transapical NeoChord implantation under beating-heart conditions with TEE guidance is safe, well-tolerated, and effectively reduces mitral regurgitation with low perioperative morbidity.
No takes yet. Share an insight, caveat, or question.
NeoChord implantation under general anesthesia was associated with low morbidity and rapid recovery; leaves open need for randomized trials versus conventional repair.
Samalavičius et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: